Get the Stockscreener App
15.67
2.02%
0.31
After Hours:
15.67
Delcath Systems Inc stock is traded at $15.67, with a volume of 207.45K.
It is up +2.02% in the last 24 hours and down -1.51% over the past month.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$15.36
Open:
$15.36
24h Volume:
207.45K
Relative Volume:
0.64
Market Cap:
$543.73M
Revenue:
$90.44M
Net Income/Loss:
$561.00K
P/E Ratio:
2,611.67
EPS:
0.006
Net Cash Flow:
$19.19M
1W Performance:
-1.26%
1M Performance:
-1.51%
6M Performance:
+56.08%
1Y Performance:
+49.81%
1-Day Range:
$15.29
$15.75
1-Week Range:
$14.52
$15.82
52-Week Range:
$8.12
$17.42
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
15.67 | 543.73M | 90.44M | 561.00K | 19.19M | 0.006 |
ABT
Abbott Laboratories
|
101.82 | 176.19B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.93 | 117.59B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
282.60 | 108.40B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.84 | 63.53B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.39 | 49.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems, Inc. Share PriceDCTH, RNS News, Articles, Quotes, & Charts (OTCMKTS: DCTH) - Proactive financial news
Delcath Systems to present at Canaccord Genuity growth conference - scanx.trade
Delcath Systems Inc. Research & Ratings | DCTH - Barron's
Delcath Systems to present at Wells Fargo and Wainwright conferences in September - scanx.trade
Delcath Systems Q2FY26 Results: Revenue up 20% to $29.1 million - scanx.trade
Delcath Systems Q2 2026 Earnings Call Transcript - Benzinga
(DCTH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Delcath Systems Inc. Research & Ratings | DCTH - Barron's
Delcath Systems Stock Price Forecast. Should You Buy DCTH? - StockInvest.us
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year? - Zacks Investment Research
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
3 Emerging Biotech Stocks With Significant Upside Potential - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock? - finance.yahoo.com
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains? - Yahoo Finance
Delcath Systems (DCTH) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Delcath Systems, Inc.(NasdaqCM:DCTH) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade - Eastern Progress
Delcath Systems, Inc. (DCTH) Stock Analysis: A Potential 47.69% Upside in the Oncology Device Market - DirectorsTalk Interviews
Are Medical Stocks Lagging Delcath Systems (DCTH) This Year? - Yahoo Finance
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule - TradingView
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Four new employees get awards tied to 34,000 Delcath shares - Stock Titan
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Delcath’s (DCTH) Liver Cancer Device Keeps Growing, But At A Cost - Yahoo Finance
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services - The Globe and Mail
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services - Yahoo Finance
Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH - TradingView
How (DCTH) Movements Inform Risk Allocation Models - Stock Traders Daily
5 Stocks With Recent Price Strength Buoyed by a Strong August - TradingView
Delcath Systems will attend two investor conferences in September - Stock Titan
Delcath Systems to Participate in Upcoming Investor Conferences - Yahoo Finance
Delcath Systems (DCTH) Holds Near $16.34 as Traders Eye Support and Resistance ZonesWide Range Bar - siam.in
Delcath Systems (DCTH) Holds Near $16.34 as Traders Eye Support and Resistance ZonesMedian Line - dars.gov.et
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why - Yahoo Finance
What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade - Yahoo Finance
Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates - Eastern Progress
Delcath (DCTH) Earnings Reading: EPS Comes in Above Forecast at the Close; Stock Move: Shares Move Lower 1.52% in Latest TradingPost-Earnings Drift - vinanet.vn
Delcath Systems Inc (DCTH) (Q2 2026) Earnings Call Highlights: R - GuruFocus
Delcath Systems Q2 2026 Earnings: EPS Surges to $0.07, Defying Loss EstimatesTrough Earnings Signal - vinanet.vn
Delcath Systems Q2 2026 Earnings: EPS Surges to $0.07, Defying Loss EstimatesGeographic Revenue Trends - dars.gov.et
DCTH Q2 2026 Earnings: EPS Flips to $0.07 vs. Expected Loss — A 176% Surprise Despite Share Pullback - vinanet.vn
Liquidity Mapping Around (DCTH) Price Events - Stock Traders Daily
Delcath Adopts Exclusive Forum Provisions in Amended Bylaws - Minichart
Delcath Systems updates bylaws to designate Delaware courts as exclusive forum - Investing.com
Delcath Systems updates bylaws to designate Delaware courts as exclusive forum - Investing.com Canada
Form 8K Delcath Systems Inc For: 14 August By Investing.com - Investing.com Australia
Delcath Systems updates bylaws to designate Delaware courts as exclusive forum - Investing.com
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sylvester John Richard | Director |
Nov 21 '25 |
Buy |
8.89 |
4,386 |
38,992 |
14,936 |
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
0.80%
3.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):